Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

This guideline updates a prior concensus recommendation of the German Society for Digestive and Metabolic Diseases (DGVS) from 1996. It was developed by an interdisciplinary cooperation with representatives of the German Society for Microbiology, the Society for Pediatric Gastroenterology and Nutrition (GPGE) and the German Society for Rheumatology. The guideline is methodologically based on recommendations of the Association of the Scientific Medical Societies in Germany (AWMF) for providing a systematic evidence-based consensus guideline of S 3 level and has also implemented grading criteria according to GRADE (Grading of Recommendations Assessment, Development and Evaluation). Clinical applicability of study results as well as specifics for Germany in terms of epidemiology, antibiotic resistance status, diagnostics and therapy were taken into account.

More information Original publication

DOI

10.1055/s-0028-1109062

Type

Journal article

Publication Date

2009-01-01T00:00:00+00:00

Volume

47

Pages

68 - 102

Total pages

34

Keywords

Adolescent, Adult, Anti-Bacterial Agents, Anti-Ulcer Agents, Child, Cross-Sectional Studies, Drug Therapy, Combination, Evidence-Based Medicine, Gastric Mucosa, Gastroscopy, Helicobacter Infections, Helicobacter pylori, Humans, Lymphoma, B-Cell, Lymphoma, B-Cell, Marginal Zone, Neoplasm Staging, Peptic Ulcer, Randomized Controlled Trials as Topic, Stomach Neoplasms